NCNA · NuCana plc ADR
United States · RS rating 16 · As of 2026-11-03
| Price | 1.00 USD |
|---|---|
| 1-day change | +2.0% |
| RS rating (overall / 1M / 3M / 12M) | 16 / 44 / 25 / 11 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 14 / 10 / 32 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +77.4% |
| Market cap (USD) | $8.9M |